JP2015530868A5 - - Google Patents

Download PDF

Info

Publication number
JP2015530868A5
JP2015530868A5 JP2015520775A JP2015520775A JP2015530868A5 JP 2015530868 A5 JP2015530868 A5 JP 2015530868A5 JP 2015520775 A JP2015520775 A JP 2015520775A JP 2015520775 A JP2015520775 A JP 2015520775A JP 2015530868 A5 JP2015530868 A5 JP 2015530868A5
Authority
JP
Japan
Prior art keywords
ifi27
level
gene product
patient
biological sample
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2015520775A
Other languages
English (en)
Japanese (ja)
Other versions
JP6097388B2 (ja
JP2015530868A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/AU2013/000765 external-priority patent/WO2014008545A1/en
Publication of JP2015530868A publication Critical patent/JP2015530868A/ja
Publication of JP2015530868A5 publication Critical patent/JP2015530868A5/ja
Application granted granted Critical
Publication of JP6097388B2 publication Critical patent/JP6097388B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2015520775A 2012-07-10 2013-07-10 インフルエンザにおけるリスクの階層化 Expired - Fee Related JP6097388B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AU2012902954A AU2012902954A0 (en) 2012-07-10 Risk stratification in influenza
AU2012902954 2012-07-10
PCT/AU2013/000765 WO2014008545A1 (en) 2012-07-10 2013-07-10 Risk stratification in influenza

Publications (3)

Publication Number Publication Date
JP2015530868A JP2015530868A (ja) 2015-10-29
JP2015530868A5 true JP2015530868A5 (enExample) 2016-06-16
JP6097388B2 JP6097388B2 (ja) 2017-03-15

Family

ID=49915252

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015520775A Expired - Fee Related JP6097388B2 (ja) 2012-07-10 2013-07-10 インフルエンザにおけるリスクの階層化

Country Status (10)

Country Link
US (2) US10036075B2 (enExample)
EP (1) EP2872891B1 (enExample)
JP (1) JP6097388B2 (enExample)
KR (1) KR20150040289A (enExample)
CN (1) CN104769430B (enExample)
AU (1) AU2013289854B2 (enExample)
BR (1) BR112015000685A2 (enExample)
CA (1) CA2877400A1 (enExample)
DK (1) DK2872891T3 (enExample)
WO (1) WO2014008545A1 (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2013217935B2 (en) 2012-02-09 2018-05-17 Memed Diagnostics Ltd. Signatures and determinants for diagnosing infections and methods of use thereof
WO2015103664A1 (en) * 2014-01-09 2015-07-16 Nepean Blue Montains Local Health District Risk stratification in influenza
RU2730836C2 (ru) 2014-08-14 2020-08-26 Мемед Диагностикс Лтд. Вычислительный анализ биологических данных с применением многообразия и гиперплоскости
EP3230740B1 (en) 2014-12-11 2025-05-21 Memed Diagnostics Ltd. Marker combinations for diagnosing infections and methods of use thereof
EP3146974A1 (en) 2015-09-25 2017-03-29 Universite Claude Bernard - Lyon 1 Biomarkers for early determination of severity of influenza related disease
WO2017149547A1 (en) * 2016-03-03 2017-09-08 Memed Diagnostics Ltd. Analyzing rna for diagnosing infection type
CA3015046A1 (en) 2016-03-03 2017-09-08 Memed Diagnostics Ltd. Rna determinants for distinguishing between bacterial and viral infections
WO2018011796A1 (en) 2016-07-10 2018-01-18 Memed Diagnostics Ltd. Early diagnosis of infections
WO2018011795A1 (en) 2016-07-10 2018-01-18 Memed Diagnostics Ltd. Protein signatures for distinguishing between bacterial and viral infections
WO2018060998A1 (en) 2016-09-29 2018-04-05 Memed Diagnostics Ltd. Methods of prognosis and treatment
WO2019236768A1 (en) * 2018-06-05 2019-12-12 Washington University Nasal genes used to identify, characterize, and diagnose viral respiratory infections
US20230176074A1 (en) * 2020-04-09 2023-06-08 B.R.A.H.M.S Gmbh Biomarkers for the diagnosis of respiratory tract infections

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5792626A (en) * 1996-09-18 1998-08-11 Incyte Pharmaceuticals, Inc. Human interferon-inducible protein
US6821724B1 (en) * 1998-09-17 2004-11-23 Affymetrix, Inc. Methods of genetic analysis using nucleic acid arrays
US7214498B2 (en) * 2001-03-23 2007-05-08 Benaroya Research Institute At Virginia Mason Tumor associated antigens and methods of using the same
JP2004121218A (ja) 2002-08-06 2004-04-22 Jenokkusu Soyaku Kenkyusho:Kk 気管支喘息または慢性閉塞性肺疾患の検査方法
JP2008504803A (ja) * 2004-01-09 2008-02-21 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア 遺伝子発現の細胞型特異的パターン
US20050244851A1 (en) * 2004-01-13 2005-11-03 Affymetrix, Inc. Methods of analysis of alternative splicing in human
WO2007034280A2 (en) * 2005-09-19 2007-03-29 Moshe Amihood Blay Composition and method for prevention of influenza
SG177956A1 (en) * 2006-08-11 2012-02-28 Baylor Res Inst Gene expression signatures in blood leukocytes permit differential diagnosis of acute infections
CN102112878A (zh) * 2008-06-06 2011-06-29 国立大学法人富山大学 用于检测流感病毒的装置
US20120009148A1 (en) * 2008-12-29 2012-01-12 Yissum Research Development Company Of The Hebrew University Of Jerusalem, Ltd. Methods of predicting responsiveness to interferon treatment and treating hepatitis c infection
WO2011008349A2 (en) * 2009-05-26 2011-01-20 Duke University Methods of identifying infectious disease and assays for identifying infectious disease
JP2014501489A (ja) * 2009-07-06 2014-01-23 アルナイラム ファーマシューティカルズ, インコーポレイテッド 細胞ベースのバイオプロセシング
WO2011038363A2 (en) * 2009-09-28 2011-03-31 The Regents Of The University Of California Beta-defensin 2 genetic variation predicts h. pylori susceptibility
US20140228243A1 (en) 2011-09-04 2014-08-14 Yissum Research Development Company Of The Hebrew University Of Jerusalem Prognostic methods and compositions for predicting interferon treatment eficacy in a subject

Similar Documents

Publication Publication Date Title
TWI329742B (enExample)
CN1910456B (zh) 视神经脊髓炎的标记
US10859573B2 (en) Nourin molecular biomarkers diagnose angina patients with negative troponin
JP2017184729A5 (enExample)
JP6755241B2 (ja) 新規分子バイオマーカーを使用して慢性閉塞性肺疾患(copd)を診断する方法
JP6755240B2 (ja) 新規分子バイオマーカーを使用して慢性閉塞性肺疾患(copd)を診断する方法
JP6097388B2 (ja) インフルエンザにおけるリスクの階層化
JP2012512389A5 (enExample)
JP2013527437A5 (enExample)
JP7463351B2 (ja) 脳卒中の血液バイオマーカー
US20110014618A1 (en) Detection of nucleic acids and proteins
CN108449999B (zh) 使用色酰胺-tRNA合成酶诊断感染病或其并发症的组合物以及检测诊断标记物的方法
JP2017519498A5 (enExample)
EP3546943A1 (en) Composition for diagnosis of diseases
JP2015505245A5 (enExample)
JP6420475B2 (ja) 細気管支炎後の喘息の診断のためのマーカーおよびその用途
JPWO2019117269A1 (ja) 膵がんの検出を補助する方法
Ishida et al. Plasma high-mobility group box 1 (HMGB1) in dogs with various diseases: comparison with C-reactive protein
US20230349889A1 (en) Methods of Determining Immune Response
JP2008547006A5 (enExample)
JP2012521549A5 (enExample)
JP2005291899A (ja) 心疾患の検査法
CN111440859A (zh) 一种人呼吸道合胞病毒感染的生物标志物及应用
JP2017077217A (ja) バイオマーカー、自己免疫性肝炎の診断補助方法、及び、キット
Hussein Correlation of CCL2, CCL5 and CXCL10 Chemokines with Disease Severity among Patients with COVID-19 Infection